CCL5 and Parkinson disease: Based on the above data, CCL5 could increase the number of Th17 cells in the spleen and in the SNpc of PD mice and promote the expression of LFA-1 on the surface of Th17 cells to facilitate the extravascular dissociation of Th17 cells.